Cognition Therapeutics Inc (NASDAQ: CGTX): To Buy Or Not To Buy, That Is The Question
Cognition Therapeutics Inc (CGTX) concluded trading on Wednesday at a closing price of $0.62, with 18.53 million shares of worth about $11.49 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.69% during that period and on July 16, 2025 the price saw a […]
Cognition Therapeutics Inc (NASDAQ: CGTX) Hogging The Spotlight Today
Currently, there are 61.97M common shares owned by the public and among those 50.00M shares have been available to trade. The company’s stock has a 5-day price change of 24.81% and -1.91% over the past three months. CGTX shares are trading -75.75% year to date (YTD), with the 12-month market performance down to -42.25% lower. […]
Growing Through Challenges? – Cognition Therapeutics Inc (CGTX)
Currently, there are 61.97M common shares owned by the public and among those 50.25M shares have been available to trade. The company’s stock has a 5-day price change of 6.77% and -26.35% over the past three months. CGTX shares are trading -54.80% year to date (YTD), with the 12-month market performance down to -84.54% lower. […]